NVDA
NVIDIA
-- 132.000 TSLA
Tesla
-- 463.020 PLTR
Palantir
-- 75.750 MSTR
MicroStrategy
-- 408.500 AVGO
Broadcom
-- 250.000 
NEWS
Amarin Receives National Reimbursement for VAZKEPA® in Italy
Monday, 16th December at 7:00 am
-- Italian Health Authorities Approve VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce Cardiovascular Risk in Eligible High-Risk Patients1 --
-- Italy is the Third EU5 Market to Grant National Reimbursement; Ninth National Reimbursement for VAZKEPA® Overall in Europe --
-- European Progress Has Advanced Patient Access: Countries That Have Provided Access to VAZKEPA Now Account for More Than 50% of the Total Established Cardiovascular Disease (eCVD) Population in Western Europe --
-- Italy Approval Further Validates the Progress Made by the Company Following Execution of a New Strategy Implemented in 2023 --
Monday, 16th December at 7:00 am
-- Italian Health Authorities Approve VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce Cardiovascular Risk in Eligible High-Risk Patients1 --
-- Italy is the Third EU5 Market to Grant National Reimbursement; Ninth National Reimbursement for VAZKEPA® Overall in Europe --
-- European Progress Has Advanced Patient Access: Countries That Have Provided Access to VAZKEPA Now Account for More Than 50% of the Total Established Cardiovascular Disease (eCVD) Population in Western Europe --
-- Italy Approval Further Validates the Progress Made by the Company Following Execution of a New Strategy Implemented in 2023 --
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment